288 related articles for article (PubMed ID: 16648288)
41. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
[TBL] [Abstract][Full Text] [Related]
42. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
Yumuk VD
Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
[TBL] [Abstract][Full Text] [Related]
43. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta.
Sharma D; Ghai S; Singh D
Gen Comp Endocrinol; 2009 Jul; 162(3):319-28. PubMed ID: 19375426
[TBL] [Abstract][Full Text] [Related]
44. The selected pathophysiological aspects of PPARs activation.
Kieć-Wilk B; Dembińska-Kieć A; Olszanecka A; Bodzioch M; Kawecka-Jaszcz K
J Physiol Pharmacol; 2005 Jun; 56(2):149-62. PubMed ID: 15985699
[TBL] [Abstract][Full Text] [Related]
45. [The male factor. I. Testicular function and gametogenesis].
Reyes A; Chavarría E; Rodríguez-Medina CM; Veldhuis JD; Rosado A
Ginecol Obstet Mex; 1997 Oct; 65():401-12. PubMed ID: 9432471
[TBL] [Abstract][Full Text] [Related]
46. [AMPK: a link between metabolism and reproduction?].
Tosca L; Chabrolle C; Dupont J
Med Sci (Paris); 2008 Mar; 24(3):297-300. PubMed ID: 18334179
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
[TBL] [Abstract][Full Text] [Related]
48. Peroxisome proliferator-activated receptors and placental function in women with polycystic ovary syndrome.
Silva A; Motta A
Reproduction; 2024 May; 167(5):. PubMed ID: 38451874
[TBL] [Abstract][Full Text] [Related]
49. The biology of the peroxisome proliferator-activated receptor system in the female reproductive tract.
Vélez LM; Abruzzese GA; Motta AB
Curr Pharm Des; 2013; 19(25):4641-6. PubMed ID: 23565653
[TBL] [Abstract][Full Text] [Related]
50. Melatonin and the ovary: physiological and pathophysiological implications.
Tamura H; Nakamura Y; Korkmaz A; Manchester LC; Tan DX; Sugino N; Reiter RJ
Fertil Steril; 2009 Jul; 92(1):328-43. PubMed ID: 18804205
[TBL] [Abstract][Full Text] [Related]
51. Expression and functional implications of peroxisome proliferator-activated receptor gamma (PPARγ) in canine reproductive tissues during normal pregnancy and parturition and at antiprogestin induced abortion.
Kowalewski MP; Meyer A; Hoffmann B; Aslan S; Boos A
Theriogenology; 2011 Mar; 75(5):877-86. PubMed ID: 21196045
[TBL] [Abstract][Full Text] [Related]
52. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Brown JD; Plutzky J
Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
[TBL] [Abstract][Full Text] [Related]
53. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
[TBL] [Abstract][Full Text] [Related]
54. Cloning, expression and investigation for polymorphisms of canine peroxisome proliferator-activated receptors.
Nishii N; Takasu M; Soe OK; Maeda S; Ohba Y; Inoue-Murayama M; Kitagawa H
Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):690-7. PubMed ID: 17512769
[TBL] [Abstract][Full Text] [Related]
55. PPARs: molecular targets in the pharmacogenomics era.
Seda O; Sedová L
Prague Med Rep; 2004; 105(3):223-36. PubMed ID: 15782550
[TBL] [Abstract][Full Text] [Related]
56. Peroxisome proliferator-activated receptor gamma expression along the male genital system and its role in male fertility.
Santoro M; De Amicis F; Aquila S; Bonofiglio D
Hum Reprod; 2020 Sep; 35(9):2072-2085. PubMed ID: 32766764
[TBL] [Abstract][Full Text] [Related]
57. The emerging roles of adiponectin in female reproductive system-associated disorders and pregnancy.
Angelidis G; Dafopoulos K; Messini CI; Valotassiou V; Tsikouras P; Vrachnis N; Psimadas D; Georgoulias P; Messinis IE
Reprod Sci; 2013 Aug; 20(8):872-81. PubMed ID: 23271161
[TBL] [Abstract][Full Text] [Related]
58. Control of adipogenesis by oxylipins, GPCRs and PPARs.
Barquissau V; Ghandour RA; Ailhaud G; Klingenspor M; Langin D; Amri EZ; Pisani DF
Biochimie; 2017 May; 136():3-11. PubMed ID: 28034718
[TBL] [Abstract][Full Text] [Related]
59. Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: Relationship to tissue development and aging.
Echeverría F; Ortiz M; Valenzuela R; Videla LA
Prostaglandins Leukot Essent Fatty Acids; 2016 Nov; 114():28-34. PubMed ID: 27926461
[TBL] [Abstract][Full Text] [Related]
60. ADAMTS proteases in fertility.
Russell DL; Brown HM; Dunning KR
Matrix Biol; 2015; 44-46():54-63. PubMed ID: 25818315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
